5-methoxy-3-[(1-propan-2-ylpiperidin-2-yl)methyl]imidazo[1,5-a]pyridine

C17H25N3O — CID 117140512

IUPAC5-methoxy-3-[(1-propan-2-ylpiperidin-2-yl)methyl]imidazo[1,5-a]pyridine
SMILESCOc1cccc2cnc(CC3CCCCN3C(C)C)n12
InChIInChI=1S/C17H25N3O/c1-13(2)19-10-5-4-7-14(19)11-16-18-12-15-8-6-9-17(21-3)20(15)16/h6,8-9,12-14H,4-5,7,10-11H2,1-3H3
InChIKeyLZLOBILGZMBMTM-UHFFFAOYSA-N
MW287.41 g/mol
LogP3.15
Rot. Bonds4

About 5-methoxy-3-[(1-propan-2-ylpiperidin-2-yl)methyl]imidazo[1,5-a]pyridine

5-methoxy-3-[(1-propan-2-ylpiperidin-2-yl)methyl]imidazo[1,5-a]pyridine (PubChem CID 117140512) has the molecular formula C17H25N3O and a molecular weight of 287.41 g/mol. Its IUPAC name is 5-methoxy-3-[(1-propan-2-ylpiperidin-2-yl)methyl]imidazo[1,5-a]pyridine.

Molecular Properties

Compound Name5-methoxy-3-[(1-propan-2-ylpiperidin-2-yl)methyl]imidazo[1,5-a]pyridine
PubChem CID117140512
Molecular FormulaC17H25N3O
Molecular Weight287.41 g/mol
Exact Mass287.20
IUPAC Name5-methoxy-3-[(1-propan-2-ylpiperidin-2-yl)methyl]imidazo[1,5-a]pyridine
SMILESCOc1cccc2cnc(CC3CCCCN3C(C)C)n12
InChIInChI=1S/C17H25N3O/c1-13(2)19-10-5-4-7-14(19)11-16-18-12-15-8-6-9-17(21-3)20(15)16/h6,8-9,12-14H,4-5,7,10-11H2,1-3H3
InChIKeyLZLOBILGZMBMTM-UHFFFAOYSA-N
XLogP3.15
TPSA29.77 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds4
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500287.41
LogP ≤ 53.15
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Analyze 5-methoxy-3-[(1-propan-2-ylpiperidin-2-yl)methyl]imidazo[1,5-a]pyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-[(1-ethylpyrrolidin-2-yl)methyl]-5-methoxyimidazo[1,5-a]pyridine
CID 117140497
3-[(1-propan-2-ylpyrrolidin-2-yl)methyl]imidazo[1,5-a]pyridine
CID 117139243
3-[(1-ethylpiperidin-3-yl)methyl]-5-methoxyimidazo[1,5-a]pyridine
CID 117140525
3-[(1-propan-2-ylpyrrolidin-2-yl)methyl]imidazo[1,5-a]pyridine-6-carbaldehyde
CID 117138556
[3-[(1-methylpyrrolidin-2-yl)methyl]imidazo[1,5-a]pyridin-5-yl]methanamine
CID 117140788
5-methoxy-3-(1-propan-2-ylpiperidin-3-yl)imidazo[1,5-a]pyridine
CID 117140458
8-methyl-3-[(1-propan-2-ylpiperidin-2-yl)methyl]-[1,2,4]triazolo[4,3-a]pyridine
CID 117146723
3-[(1-propan-2-ylpyrrolidin-2-yl)methyl]imidazo[1,5-a]pyridin-8-amine
CID 117146657
5-chloro-3-[(1-propan-2-ylpyrrolidin-2-yl)methyl]-[1,2,4]triazolo[4,3-a]pyridine
CID 117141708
3-(1-propan-2-ylpiperidin-2-yl)imidazo[1,5-a]pyridin-5-ol
CID 117141639
3-[(3-bromophenyl)methyl]-5-methoxyimidazo[1,5-a]pyridine
CID 117140557
1-(5-methoxyimidazo[1,5-a]pyridin-3-yl)-N-methylethanamine
CID 117253085

Frequently Asked Questions

What is the IUPAC name of 5-methoxy-3-[(1-propan-2-ylpiperidin-2-yl)methyl]imidazo[1,5-a]pyridine?
The IUPAC name of 5-methoxy-3-[(1-propan-2-ylpiperidin-2-yl)methyl]imidazo[1,5-a]pyridine (CID 117140512) is 5-methoxy-3-[(1-propan-2-ylpiperidin-2-yl)methyl]imidazo[1,5-a]pyridine.
What is the SMILES notation for 5-methoxy-3-[(1-propan-2-ylpiperidin-2-yl)methyl]imidazo[1,5-a]pyridine?
The canonical SMILES for 5-methoxy-3-[(1-propan-2-ylpiperidin-2-yl)methyl]imidazo[1,5-a]pyridine is COc1cccc2cnc(CC3CCCCN3C(C)C)n12.
What is the InChIKey of 5-methoxy-3-[(1-propan-2-ylpiperidin-2-yl)methyl]imidazo[1,5-a]pyridine?
The InChIKey is LZLOBILGZMBMTM-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H25N3O/c1-13(2)19-10-5-4-7-14(19)11-16-18-12-15-8-6-9-17(21-3)20(15)16/h6,8-9,12-14H,4-5,7,10-11H2,1-3H3.
What are the key properties of 5-methoxy-3-[(1-propan-2-ylpiperidin-2-yl)methyl]imidazo[1,5-a]pyridine?
5-methoxy-3-[(1-propan-2-ylpiperidin-2-yl)methyl]imidazo[1,5-a]pyridine has a molecular weight of 287.41 g/mol, XLogP of 3.15, 4 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 5-methoxy-3-[(1-propan-2-ylpiperidin-2-yl)methyl]imidazo[1,5-a]pyridine is sourced from PubChem (CID 117140512), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).